Raras
Buscar doenças, sintomas, genes...
Doença ocular tipo ilha Aland
ORPHA:178333CID-10 · H35.5CID-11 · 9B7YOMIM 300600DOENÇA RARA

Uma doença de retina genética, ligada ao cromossomo X, que causa pouca pigmentação no fundo do olho, visão reduzida, movimentos involuntários dos olhos (nistagmo), astigmatismo, miopia progressiva (que faz o olho alongar), dificuldade para enxergar no escuro e dificuldade para diferenciar as cores vermelho e verde (protanopia).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença de retina genética, ligada ao cromossomo X, que causa pouca pigmentação no fundo do olho, visão reduzida, movimentos involuntários dos olhos (nistagmo), astigmatismo, miopia progressiva (que faz o olho alongar), dificuldade para enxergar no escuro e dificuldade para diferenciar as cores vermelho e verde (protanopia).

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
5
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
5 sintomas
🧬
Pele e cabelo
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

100%prev.
Astigmatismo
Muito frequente (99-80%)
100%prev.
Hipoplasia da fóvea
Muito frequente (99-80%)
100%prev.
Miopia
Muito frequente (99-80%)
100%prev.
Hipopigmentação do fundo de olho
Muito frequente (99-80%)
100%prev.
Acuidade visual severamente reduzida
Frequência: 6/6
100%prev.
Protanopia
Frequência: 6/6
13sintomas
Muito frequente (11)
Muito raro (1)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 13 características clínicas mais associadas, ordenadas por frequência.

AstigmatismoAstigmatism
Muito frequente (99-80%)100%
Hipoplasia da fóveaHypoplasia of the fovea
Muito frequente (99-80%)100%
MiopiaMyopia
Muito frequente (99-80%)100%
Hipopigmentação do fundo de olhoHypopigmentation of the fundus
Muito frequente (99-80%)100%
Acuidade visual severamente reduzidaSeverely reduced visual acuity
Frequência: 6/6100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2025142 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.

CACNA1FVoltage-dependent L-type calcium channel subunit alpha-1FDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 2A

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

OUTRAS DOENÇAS (4)
congenital stationary night blindness 2AX-linked cone-rod dystrophy 3Aland island eye diseasecone-rod dystrophy
HGNC:1393UniProt:O60840

Variantes genéticas (ClinVar)

420 variantes patogênicas registradas no ClinVar.

🧬 CACNA1F: NM_001256789.3(CACNA1F):c.2151C>A (p.Phe717Leu) ()
🧬 CACNA1F: NM_001256789.3(CACNA1F):c.5436T>A (p.Tyr1812Ter) ()
🧬 CACNA1F: NM_001256789.3(CACNA1F):c.1438del (p.Ala480fs) ()
🧬 CACNA1F: NM_001256789.3(CACNA1F):c.3420T>A (p.Cys1140Ter) ()
🧬 CACNA1F: NM_001256789.3(CACNA1F):c.1165del (p.Gln389fs) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença ocular tipo ilha Aland

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

The role of noninfectious comorbidities in the association between severe infections and risk of dementia in Finland: A nationwide registry study.

PLoS medicine2026 Mar

Severe infections have been linked to an increased risk of dementia, but both conditions often coexist with other illnesses that may confound this association. Using nationwide Finnish health registry data, we examined the role of noninfectious mental and physical illnesses in the association between severe infections and dementia. This register-based study included 62,555 individuals aged 65 or older in Finland in 2016 who were diagnosed with late-onset dementia between 2017 and 2020 and 312,772 dementia-free controls matched for year of birth, sex, and the follow-up period. Analyses were adjusted for education, marital status, employment, and area of residence, with age and sex accounted for through the matched conditional design and analysis. Applying a 1-year lag period, we identified 29 hospital-treated diseases that occurred 1-21 years before dementia diagnosis in cases (or index date in controls), had a prevalence of ≥ 1% prior to dementia, and were robustly associated with increased dementia risk (confounder-adjusted rate ratio ≥ 1.20, p < 0.000294). In addition to 2 infectious diseases (cystitis and bacterial infection of an unspecified site), these included 27 mental, behavioural, digestive, endocrine, cardiometabolic, neurological, and eye diseases, as well as injuries. 29,376 (47%) of the dementia cases had at least one of these diseases diagnosed before dementia. The associations between the two infectious diseases and dementia risk were not attributable to the 27 comorbid dementia-related diseases diagnosed before infections. The adjusted rate ratio for cystitis was 1.22 (95% confidence interval (CI) [1.17, 1.27]; p < 0.001) before and 1.19 (95% CI [1.14, 1.24]; p < 0.001) after adjustment for comorbidities, while for bacterial infections of an unspecified site, the rate ratios were 1.21 (95% CI [1.16, 1.28]; p < 0.001) and 1.19 (95% CI [1.13, 1.25]; p < 0.001), respectively. The findings were comparable across subgroups defined by sex and education, and stronger for cases of early onset dementia. We were not able to directly assess psychosocial, behavioural, or biological confounders that are not captured in nationwide registries. This nationwide Finnish study identified several mental and physical diseases that are associated with an increased risk of dementia and showed that the increased incidence of dementia among individuals with severe infections is not attributable to these comorbid conditions. These results support the role of severe infections as independent risk factors for dementia.

#2

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 16

Biallelic DIAPH1 pathogenic variants cause a neurodevelopmental syndrome occasionally associated with immunodeficiency. This study aims to define the clinical and immunological spectrum of DIAPH1-related neuroimmunological syndrome and explore the gene's developmental role using vertebrate models. 53 individuals with biallelic DIAPH1 variants, including 33 previously unreported patients were studied. Clinical features were analysed and functional studies were conducted using knockout models in Danio rerio and Xenopus tropicalis. Clinical features included developmental delay, intellectual disability, progressive microcephaly, cortical visual impairment or blindness, epilepsy, and frequent occipital-predominant brain abnormalities. Almost half suffered from infections, mainly affecting their respiratory tract related to epilepsy and aspiration. Although the majority had normal lymphocyte subsets and serum immunoglobulins, T-cell receptor excision circles and naïve T-lymphocyte counts were consistently low. The Xenopus model mirrored growth and eye defects seen in humans, while zebrafish exhibited no overt malformations but showed seizure-like behaviour in Phenothiazine assays. DIAPH1 is critical for neurodevelopment, immune regulation, and DNA repair. The DNA repair defect may influence susceptibility to infection, lymphoma, or treatment-related toxicity. Although absolute T-cell numbers are not consistent with SCID, impaired T-cell maturation suggests these patients could be identified by TREC newborn screening before neurological symptoms develop.

#3

Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Oncology2026 Mar

Breast cancer is a leading cause of mortality and morbidity among females worldwide. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, we provided an updated comprehensive assessment of the epidemiological trends, disease burden, and risk factors associated with breast cancer globally, regionally, and nationally from 1990 to 2023. Breast cancer incidence, mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) were estimated by age and sex for 204 countries and territories from 1990 to 2023. Mortality estimates were generated using GBD Cause of Death Ensemble models, leveraging data from population-based cancer registration systems, vital registration systems, and verbal autopsies. Mortality-to-incidence ratios were calculated to derive both mortality and incidence estimates. Prevalence was calculated by combining incidence and modelled survival estimates. YLLs were established by multiplying age-specific deaths with the GBD standard life expectancy at the age of death. YLDs were estimated by applying disability weights to prevalence estimates. The sum of YLLs and YLDs equalled the number of DALYs. Breast cancer burden attributable to seven risk factors was examined through the comparative risk assessment framework. The GBD forecasting framework was used to forecast breast cancer incidence and mortality from 2024 to 2050. Age-standardised rates were calculated for each metric using the GBD 2023 world standard population. In 2023, there were an estimated 2·30 million (95% uncertainty interval [UI] 2·01 to 2·61) breast cancer incident cases, 764 000 deaths (672 000 to 854 000), and 24·1 million (21·3 to 27·5) DALYs among females globally. In the World Bank low-income group, where a low age-standardised incidence rate (ASIR) was estimated (44·2 per 100 000 person-years [31·2 to 58·4]), the age-standardised mortality rate (ASMR) was the highest (24·1 per 100 000 [16·8 to 31·9]). The highest ASIR was in the high-income group (75·7 per 100 000 [67·1 to 84·0]), and the lowest ASMR was in the upper-middle-income group (11·2 per 100 000 [10·2 to 12·3]). Between 1990 and 2023, the ASIR in the low-income group increased by 147·2% (38·1 to 271·7), compared with a 1·2% (-11·5 to 17·2) change in the high-income group. The ASMR decreased in the high-income group, changing by -29·9% (-33·6 to -25·9), but increased by 99·3% (12·5 to 202·9) in the low-income group. The increase in age-standardised DALY rates followed that of ASMRs. Risk factors such as dietary risks, tobacco use, and high fasting plasma glucose contributed to 28·3% (16·6 to 38·9) of breast cancer DALYs in 2023. The risk factors with a decrease in attributable DALYs between 1990 and 2023 were high alcohol use and tobacco. By 2050, the global incident cases of breast cancer among females were forecast to reach 3·56 million (2·29 to 4·83), with 1·37 million (0·841 to 2·02) deaths. The stable incidence and declining mortality rates of female breast cancer in high-income nations reflect success in screening, diagnosis, and treatment. In contrast, the concurrent rise in incidence and mortality in other regions signals health system deficits. Without effective interventions, many countries will fall short of the WHO Global Breast Cancer Initiative's ambitious target of achieving an annual reduction of 2·5% in age-standardised mortality rates by 2040. The mounting breast cancer burden, disproportionately affecting some of the world's most vulnerable populations, will further exacerbate health inequalities across the globe without decisive immediate action. Gates Foundation, St Jude Children's Research Hospital.

#4

Integrative Proteogenomic Analysis Identifies Genetically Supported Plasma Proteins, Metabolites, and Pathways in Glaucoma.

Investigative ophthalmology &amp; visual science2026 Feb 02

Glaucoma is a leading cause of irreversible blindness, yet the circulating proteins and metabolic pathways that causally contribute to different glaucoma subtypes remain poorly defined. We analyzed baseline plasma proteomics in 1485 glaucoma cases (447 primary open‑angle glaucoma [POAG], 177 primary angle-closure glaucoma [PACG], 120 normal-tension glaucoma [NTG]) in the UK Biobank using Cox models with graded adjustment. We then integrated five independent protein quantitative trait loci resources with FINLAND R12 genome-wide association study data to perform two‑sample Mendelian randomization (MR) and cross‑cohort meta‑analysis for overall glaucoma and each subtype. To prioritize effector genes and pathways, we conducted summary-data-based Mendelian randomization (SMR) using eQTLGen and two‑step mediation MR using metabolite quantitative trait loci data for ∼1400 plasma metabolites from the Canadian Longitudinal Study on Aging cohort. In fully adjusted Cox models, 484 proteins were associated with incident glaucoma, 135 with NTG, 59 with POAG, and 1 with PACG (false discovery rate <0.05). Multicohort MR and meta‑analysis identified eight proteins with robust causal effects: NRP2, TSPAN1, and HAVCR2 for overall glaucoma; NRXN3 for PACG; MANSC4 for NTG; and LTBP2, CD69, and SMAD1 for POAG. SMR supported NRP2 (overall glaucoma) and SMAD1 (POAG) as causal genes. Mediation MR revealed that sphingomyelins, acylcarnitines, and bile acid-related metabolites partially mediated the effects of several proteins, defining shared (e.g., sphingolipid) and subtype‑specific metabolic pathways. By integrating epidemiologic, proteomic, genetic, and metabolomic data, we identify convergent systemic protein and metabolic signatures associated with glaucoma susceptibility and its clinical subtypes. These findings nominate NRP2, SMAD1, and related pathways as promising biomarkers and therapeutic targets and support a systems‑level view of glaucoma pathogenesis beyond intraocular pressure alone.

#5

A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion.

The New England journal of medicine2026 Jan 29

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving adults with acute, nonarteritic central retinal artery occlusion who had symptom onset within 4.5 hours before treatment. Patients were assigned, in a 1:1 ratio, to receive intravenous tenecteplase (at a dose of 0.25 mg per kilogram of body weight) and oral placebo or intravenous placebo and oral aspirin (at a dose of 300 mg). The primary end point was vision recovery, defined as a best corrected visual acuity (BCVA) in the affected eye at 30 days of up to 0.7 logMAR (logarithm of the minimum angle of resolution; equivalent to ≥20/100). Key secondary visual end points were a BCVA of up to 0.5 logMAR (equivalent to ≥20/63), mean improvement in BCVA, and perimetry score at 30 days. Key safety end points included symptomatic intracranial hemorrhage, major bleeding, and death. A total of 78 patients at 16 sites in six countries underwent randomization, with 40 assigned to receive tenecteplase and 38 to receive aspirin. At 30 days, 8 patients (20%) in the tenecteplase group and 9 patients (24%) in the aspirin group had vision recovery (risk difference, -3.7 percentage points; 95% confidence interval, -22.0 to 14.7; P = 0.69). The outcomes with regard to the secondary visual end points did not differ substantially between the groups. There was a greater incidence of adverse events in the tenecteplase group, including one fatal intracranial hemorrhage. Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion did not result in significantly greater vision recovery at 30 days than oral aspirin but was associated with serious safety concerns. (Funded by Oslo University Hospital and others; TenCRAOS ClinicalTrials.gov number, NCT04526951; EU Clinical Trials number, 2024-517606-29-00.).

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 198

2026

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy
2026

The role of noninfectious comorbidities in the association between severe infections and risk of dementia in Finland: A nationwide registry study.

PLoS medicine
2025

Poor glycemic control impairs recovery from central retinal vein occlusion.

Molecular vision
2026

Trends, hotspots, and future directions of inflammation in age-related macular degeneration: A 20-year bibliometric study.

Medicine
2026

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021.

The Korean journal of internal medicine
2026

Aberrant angiogenesis, inflammation, and fibrosis in pediatric vitreoretinal surgical diseases.

Survey of ophthalmology
2026

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology.

Orphanet journal of rare diseases
2026

Overproduction of 42 Amino Acids Long Amyloid Beta Leads to Activation of Secretory Autophagy and Development of Drusen-Like Structures Originating From Retinal Pigment Epithelium.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Oncology
2026

Bidirectional causal associations between immune cell phenotypes and age-related macular degeneration subtypes: A mendelian randomization study.

Experimental gerontology
2026

Identification of Two Novel Mutations in the CHM Gene Causing Choroideremia.

American journal of medical genetics. Part A
2026

Functional polymorphisms in pigmentation-related genes MC1R and DCT display population-specific association with wet age-related macular degeneration.

Biochemistry and biophysics reports
2026

Caveolar Endocytosis Governs Nanoneedle Transfection.

ACS nano
2026

Integrative Proteogenomic Analysis Identifies Genetically Supported Plasma Proteins, Metabolites, and Pathways in Glaucoma.

Investigative ophthalmology &amp; visual science
2026

Randomized, single-centre, double-blinded repeated dose investigation of safety and tolerability of ocular administrations of a novel silica eye drop product in healthy volunteers.

Acta ophthalmologica
2026

Surgery or Symptom-Based Management? Resolving the 50-Year Debate on Orbital Blowout Fractures.

Plastic and reconstructive surgery
2026

Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes.

Environment international
2026

Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society
2026

Female sex is a risk factor for exacerbated lipid peroxidation and disease in murine retinitis pigmentosa.

Redox biology
2026

A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion.

The New England journal of medicine
2026

The socioeconomic impact of inherited retinal dystrophies (IRDs) in Belgium: A cost-of-illness study.

PloS one
2026

Direct and indirect costs associated with declining distance visual acuity: A nationwide longitudinal cost-of-illness study with 11-year follow-up.

Acta ophthalmologica
2026

A novel EYS c.6192-1G>A variant presents ideal base editing therapeutic opportunities.

Ophthalmic genetics
2026

Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Respiratory medicine
2026

Healing of ischemic injury in the retina.

Science advances
2026

Altered tear fluid protein expression in persons with mild cognitive impairment.

Journal of Alzheimer's disease : JAD
2026

Large-scale blood pressure GWAS accounting for gene-depression interactions in 564,680 individuals from diverse populations.

HGG advances
2026

REACT-PXE: a consensus on diagnosis and future research concerning pseudoxanthoma elasticum (PXE).

Annales de dermatologie et de venereologie
2026

Minimally Invasive, Label-Free, Point-of-Care Histopathological Diagnostic Platform of Malignant Tumors of the Female Reproductive System Based on Raman Spectroscopy and Machine Learning.

The journal of physical chemistry letters
2026

Characterization of genetic loci associated with allergic conjunctivitis.

The Journal of allergy and clinical immunology
2025

Large-Scale Gene-Smoking Interactions and Fine Mapping Study Identifies Multiple Novel Blood Pressure Loci in over 1 Million Individuals.

medRxiv : the preprint server for health sciences
2026

IMPG2-associated retinal dystrophy with a novel missense variant and therapeutic options via adenine base editing.

Ophthalmic genetics
2026

Eye-tracking saccade parameters reveal early cognitive decline in relation to Clinical Dementia Rating-Sum of Boxes scores.

Journal of Alzheimer's disease : JAD
2026

Insights into KIF11 pathogenesis in microcephaly-lymphedema-chorioretinopathy syndrome from a lymphatic perspective.

JCI insight
2025

Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Infectious diseases
2025

Impact of complications in adult anterior uveitis in a Finnish single-centre registry study.

BMJ open ophthalmology
2025

Presynaptic Changes in Mouse Rod Photoreceptors During Early Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2025

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Allergy
2025

Food allergy severity across the world: A World Allergy Organization international survey.

The World Allergy Organization journal
2025

Global, regional and national burden and trends of sense organ diseases from 1990 to 2021: based on the Global Burden of Disease (GBD) study.

BMJ open
2026

C-terminal extension of HSPB6 in a family with myopathy and cataract.

Human molecular genetics
2026

Development and psychometric validation of the Chronic Rhinosinusitis Control Test.

Rhinology
2025

Clinical consensus on vestibular infant screening.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2026

Progressive rod bipolar cell loss, ubiquitin accumulation, and subretinal drusenoid deposits in Cln3Δex7/8 mice: New insights into juvenile neuronal ceroid lipofuscinosis pathogenesis.

Experimental eye research
2026

Integrated surface-enhanced Raman spectroscopy and machine learning for identification and quantification of multi-target pesticide residues in fruit juices.

Food chemistry
2026

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Allergy
2025

Sleep deprivation and sleep intensity exert distinct effects on cerebral vasomotion and brain pulsations driven by the respiratory and cardiac cycles.

PLoS biology
2025

Vision impairment is a risk factor for malnutrition in older long-term care residents.

European geriatric medicine
2025

Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Neurology
2026

Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes.

American journal of medical genetics. Part A
2025

Altered GABAergic signaling and chloride homeostasis in eye movement circuits during late neurodevelopment: implications for Alzheimer's disease therapy.

Frontiers in pharmacology
2025

A Novel Manual "Centrifuged-Enhanced" Cytosmear Technique for Improving Hypocellular Cytology in the Diagnosis of Vitreoretinal Lymphoma.

Translational vision science &amp; technology
2025

Levodopa exposure and nigral neuroinflammation in parkinsonian disorders: A postmortem study of 63 cases.

Scientific reports
2025

Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England)
2025

Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors.

Molecular therapy. Nucleic acids
2025

Survival benefits of antipredator training in captive-reared salmon: impact of behaviour, health, and genetics.

Oecologia
2025

Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state.

Journal of neuroinflammation
2025

Non-damaging laser treatment with electroretinography-based thermal dosimetry activates hormetic heat response in pig retinal pigment epithelium.

Nature communications
2025

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in UK children: Outcomes from a 2-year multi-site interventional trial.

Ophthalmic &amp; physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
2025

Assessing Critical Care Delivery Using National-Level ICU Registry Data.

Critical care medicine
2025

Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis.

The Lancet. Global health
2025

Exome and Genome Sequencing Reveals Novel Variants for Severe Diabetic Retinopathy in Type 1 Diabetes.

Investigative ophthalmology &amp; visual science
2025

PREVALENCE AND DEGREE OF RETINAL VASCULATURE ALTERATIONS IN ADULTS BORN PRETERM WITH VERY LOW BIRTH WEIGHT: A Birth Cohort Study.

Retina (Philadelphia, Pa.)
2025

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England)
2025

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England)
2025

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England)
2025

Marfan Europe Network: Together we can!

FEBS letters
2026

Association of Ocular Comorbidities on Long-term Patient-Reported Outcome Measures After Multifocal Intraocular Lens Implantation.

American journal of ophthalmology
2025

Absorbable Sutures are Equally Efficacious to Non-absorbable Sutures in Upper Eyelid Blepharoplasty for Dermatochalasis: A Comparative Study.

Aesthetic plastic surgery
2025

Factors associated with the high prevalence of myopia and its decrease-A historical review.

Acta ophthalmologica
2026

Long-read sequencing uncovers novel pathogenic duplications in the PRPH2 gene in patients with macular dystrophy.

Ophthalmic genetics
2025

Transmembrane and multiplexin collagens in development and pathobiology.

Matrix biology : journal of the International Society for Matrix Biology
2025

Self-Assembled Plasmonic Magnifier: A New Platform for Ultra-Sensitive Detection of Respiratory Viruses Using Surface-Enhanced Raman Spectroscopy.

Analytical chemistry
2025

Intravitreal Sustained Release of Dexamethasone from a Self-Healing Injectable Hydrogel: An In Vivo Safety and Release Study.

Molecular pharmaceutics
2025

Factors associated with eye examination within the past year among older home care clients: A cross-sectional register study.

Optometry and vision science : official publication of the American Academy of Optometry
2025

The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England)
2025

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.

Journal of the American College of Cardiology
2025

RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.

Investigative ophthalmology &amp; visual science
2025

Comprehensive characterization of the rat magnetic microbead model using longitudinal monitoring of structural and functional parameters.

Experimental eye research
2025

New insights on liposomal formulations based upon tear film lipids: A combined study of safety and ocular surface pharmacokinetics.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2025

The global, regional, and national burden attributable to low bone mineral density, 1990-2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021.

The Lancet. Rheumatology
2025

Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma.

Pigment cell &amp; melanoma research
2025

A magnetic coupled organic SERS platform integrating acetonitrile-driven microextraction and hotspot enrichment: A new strategy for highly sensitive and precise detection of drug molecules in complex matrices.

Biosensors &amp; bioelectronics
2025

Surgical options for correcting refractive surprise after cataract and lens surgery: review and meta-analysis.

Journal of cataract and refractive surgery
2025

SERS technology in virus Detection: Advances, challenges, and future perspectives.

Biosensors &amp; bioelectronics
2025

The Prevalence of Myopia in Finnish Conscripts Has not Increased in Recent Decades and Is Lower Than in Many East and Southeast Asian Countries.

Investigative ophthalmology &amp; visual science
2025

A whole-brain male mouse atlas of long-range inputs to histaminergic neurons.

Nature communications
2026

Deep Learning-Based Detection of Papilledema on Retinal Photographs From Handheld Cameras: A Prospective Study.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Forecasting trends in glaucoma medication reimbursees in Finland: updated system dynamics model to 2070.

BMJ open ophthalmology
2025

Repurposing Drug Metabolites into Dual β-Adrenergic Receptor-Carbonic Anhydrase Modulators as Potential Tools for Ocular Disorders.

Journal of medicinal chemistry
2026

Role of cognitive function in the reliability and results of standard automated perimetry.

European journal of ophthalmology
2024

Functional Vision Questionnaire Detects Near Triad Impairments in Adolescent Athletes With Concussion History.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2025

Q-value individualized CLEAR lenticule extraction preserves corneal asphericity and minimizes spherical aberration while maintaining optical zone predictability.

Scientific reports
2025

Real-World Evaluation of Artificial Intelligence-Based Diabetic Retinopathy Screening Using the Optomed Aurora Handheld Fundus Camera.

Diabetes technology &amp; therapeutics
2025

Increased frontal [123I]FP-CIT binding in Parkinson's disease patients with self-reported REM sleep behavior disorder.

NPJ Parkinson's disease
2025

AI-assisted two-step enhanced SERS platform for rapid and ultra-sensitive detection of toxic molecules in biofluids.

Biosensors &amp; bioelectronics
2025

Early Emerging Gradients in Children's Eye Movement Times Across Levels of Household Resources.

Developmental science
2026

Competency-based European training requirements for the specialty of ophthalmology. Recommendations from the UEMS section of ophthalmology and the European Board of Ophthalmology.

Acta ophthalmologica
2025

Repurposed clindamycin suppresses pyroptosis in tumor-associated macrophages through Inhibition of caspase-1.

Journal of experimental &amp; clinical cancer research : CR
2025

Update on sleep disorders in advanced Parkinson's disease: a narrative review.

Journal of neural transmission (Vienna, Austria : 1996)
2026

Comparative analysis of cycloplegic and non-cycloplegic refraction techniques for assessing refractive error in adults: a population-based study.

Clinical &amp; experimental optometry
2025

Diffuse infiltrating retinoblastoma: a multicentre, international, data-sharing study.

The British journal of ophthalmology
2025

Inborn Errors of Metabolism: Gyrate Atrophy.

Advances in experimental medicine and biology
2025

Selection of locally administered ocular tissue-targeting RNA aptamers using in vivo SELEX.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2026

Highly sensitive detection of cervical cancer biomarker miR-21 using surface-enhanced Raman scattering (SERS).

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2025

Metacercariae of Diplostomum spp. from eyes of the Bullhead Cottus koshewnikowi Gratzianov, 1907 from the northern European watershed.

Journal of helminthology
2026

ESR Essentials: acute infections of the head and neck-practice recommendations by the European Society of Head and Neck Radiology.

European radiology
2026

Unilateral optic neuritis and thinning of retinal layers in the affected and unaffected eyes.

Acta ophthalmologica
2025

Polygenic prediction of body mass index and obesity through the life course and across ancestries.

Nature medicine
2026

Secretory autophagy and epithelial-to-mesenchymal transition in cadaveric AMD samples: Novel pathways in disease progression.

Acta ophthalmologica
2025

Overcoming Fluorescence Interference: "Planar Hotspot" Substrates for Vitamin B Detection with SERS.

Analytical chemistry
2026

Prognostic factors for dysphotopsia and spectacle-independent visual function after implantation of non-diffractive extending focus intraocular lenses.

Acta ophthalmologica
2025

Occurrence and outcomes of retrobulbar haematoma in 2149 orbital fracture patients.

Oral and maxillofacial surgery
2026

Fellowships across Europe: Insights from the European Board of Ophthalmology Survey.

Acta ophthalmologica
2025

Cyclic nucleotide signaling as a drug target in retinitis pigmentosa.

FEBS letters
2025

Real-world outcomes of early and deferred anti-VEGF treatment in diabetic macular oedema in patients with type 1 diabetes.

Annals of medicine
2025

Loss of CFHR5 function reduces the risk for age-related macular degeneration.

Nature communications
2025

Conformational eyelid disorders in dogs under primary veterinary care in the UK - Epidemiology and clinical management.

PloS one
2025

Artificial Intelligence-Based Detection of Central Retinal Artery Occlusion Within 4.5 Hours on Standard Fundus Photographs.

Journal of the American Heart Association
2025

Characterisation and prevalence of inherited retinal diseases in the Finnish population reveals enrichment of population-specific phenotypes and causative variants.

The British journal of ophthalmology
2025

High activity of human cytomegalovirus in patients with Sjögren's disease.

Clinical immunology (Orlando, Fla.)
2025

Multi-ancestry genome-wide association analyses incorporating SNP-by-psychosocial interactions identify novel loci for serum lipids.

Translational psychiatry
2025

Lesion-Induced Blepharospasm: Epidemiology and Clinical Characteristics.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

The incidence of serious complications after selective laser trabeculoplasty.

Acta ophthalmologica
2025

Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial.

European stroke journal
2025

Insight into human photoreceptor function: Modeling optoretinographic responses to diverse stimuli.

Science advances
2025

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.

Advances in therapy
2025

The role of secretory autophagy and exosomes in the accumulation of drusen during the development of age-related macular degeneration (AMD).

Ageing research reviews
2025

Neuroinflammation Markers in Tear Fluid of Mild Alzheimer's Disease.

Journal of molecular neuroscience : MN
2025

Compartmentalized 3D bioprinting of the limbal niche with distinct hPSC-LSC subpopulations for corneal disease modeling.

Acta biomaterialia
2025

Cataract surgical training in Poland: analysis of the European board of ophthalmology survey results.

BMC medical education
2025

Serum RNA Profile Reflects Fluid Status and Atrophic Retinal Changes in Neovascular Age-Related Macular Degeneration.

International journal of molecular sciences
2025

Area Under the Curve Analysis in a Real-World Cohort of Finnish Patients Treated for Neovascular Age-Related Macular Degeneration.

Translational vision science &amp; technology
2025

Automated Diabetic Retinopathy Screening in Out-patient Diabetes Care - Comparison of Two Artificial Intelligence Algorithms: RetCAD and OphtAI.

Klinische Monatsblatter fur Augenheilkunde
2025

Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.

JAMA neurology
2026

Progression and topographic subtypes of Terrien marginal degeneration.

Acta ophthalmologica
2026

Outsourced eye care in the Finnish capital region: Switching from fee-for-service to bundled payment model.

Acta ophthalmologica
2025

Novel Pathogenic Variants in IFT140 and IFT172 Genes in Three Patients with Similar Retinal Dystrophy Phenotypes.

Case reports in ophthalmology
2025

Innovative application of confocal Raman spectroscopy and Machine learning in cardiovascular diseases identification.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2025

Effect of anticholinergic eye drops on intraorbital, periorbital and brain pulsation power.

Acta ophthalmologica
2025

Comparison of Customized and Standard Corneal Cross-linking for Ectasia After Laser in Situ Keratomileusis.

Journal of refractive surgery (Thorofare, N.J. : 1995)
2025

Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.

Nature communications
2025

Orbital exenteration in the management of orbital and periorbital tumours: Factors related to treatment outcomes.

Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS
2025

Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma.

Nature communications
2025

Potential of autophagy in subretinal fibrosis in neovascular age-related macular degeneration.

Cellular &amp; molecular biology letters
2025

Drivers Shaping Spillover of Aleutian Mink Disease Virus Introduced With American Mink Among Native Mustelids.

Transboundary and emerging diseases
2025

The Impacts of Caregiving for Patients with X-Linked Retinitis Pigmentosa (XLRP): Findings from the EXPLORE XLRP-2 Study.

Advances in therapy
2025

Evaluation of a New Non-Mydriatic Handheld Fundus Camera for Fundus Imaging in Cats: A Retrospective Study: 208 Cases (2023-2024).

Veterinary medicine and science
2025

In vitro biophysical and biological profiling of commercial lipid-based dry eye products.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2025

Reproducibility and reliability of intraocular pressure self-measurement with iCare® HOME2 compared to Goldmann applanation tonometry.

Journal francais d'ophtalmologie
2025

Genetic Risk for Open-Angle Glaucoma Subtypes Is Associated with Specific Visual Field Defect Classes.

Ophthalmology
2025

Common variants in the CPT1A gene are associated with cataracts in Northern breeds of domestic dog.

PloS one
2025

Altered tear fluid protein expression in persons with mild Alzheimer's disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism.

Journal of Alzheimer's disease : JAD
2025

Circadian clock disruption promotes retinal photoreceptor degeneration.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Oculoplastic complications in patients with adenoviral keratoconjunctivitis.

Orbit (Amsterdam, Netherlands)
2025

Uncovering potential interviewer-related biases in self-efficacy assessment: a study among chronic disease patients.

BMC psychology
2025

Blood pressure in childhood, young- and mid-adulthood: association with carotid plaque severity.

European heart journal
2025

Enzyme Replacement Therapy in CLN2-Associated Retinopathy.

Klinische Monatsblatter fur Augenheilkunde
2025

Etiology of Anterior Uveitis in a Finnish Single-Center Register Study - Differences in Clinical Characteristics, Treatment Outcomes, and Ocular Complications.

Ocular immunology and inflammation
2025

Advanced SERSome-based artificial-intelligence technology for identifying medicinal and edible homologs.

Talanta
2025

Advances in environmental pollutant detection techniques: Enhancing public health monitoring and risk assessment.

Environment international
2025

Correlation between aqueous flare levels and anti-VEGF treatment response in wet age-related macular degeneration.

European journal of ophthalmology
2025

Prevalence and associated factors of reduced visual acuity and undercorrected refractive error in Finland: Results from a nationwide survey.

Acta ophthalmologica
2026

Effect of Customized Corneal Crosslinking on Patients With Pellucid Marginal Degeneration.

Cornea
2025

Errors and Delays in Diagnosing Keratitis Fugax Hereditaria.

American journal of ophthalmology
2025

Reliability of Self-Monitoring of Intraocular Pressure With iCare Home2 Rebound Tonometry.

Journal of glaucoma
2025

Surface-enhanced Raman spectroscopy in pharmaceutical analysis: from component determination to mechanism research.

Mikrochimica acta
2025

Novel MYH10 heterozygous variants associated to a syndrome combining mainly ptosis and ocular coloboma expand the MYH10 related phenotypes.

European journal of human genetics : EJHG
2025

Delivery of Fenofibrate to Ocular Tissues using 2-Hydroxypropyl-β-cyclodextrin-Based Micelles.

International journal of pharmaceutics
2025

Protective Role and Enhanced Intracellular Uptake of Curcumin in Retinal Cells Using Self-Emulsifying Drug Delivery Systems (SNEDDS).

Pharmaceuticals (Basel, Switzerland)
2025

Oil-in-water nanoemulsions for glaucoma treatment: An insight into the latest trends.

BioImpacts : BI
2024

Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors.

Molecular vision
2025

Overlap in the diagnostic criteria of frontotemporal dementia syndromes with parkinsonism.

Journal of Alzheimer's disease : JAD
2025

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2025

Assign a systematic traumatological status in orbital fracture patients - A prospective cohort study.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2025

Validation of manually scored multichannel frontal electroencephalography against polysomnography in a paediatric cohort.

Journal of sleep research
2025

Prototype master protocol for benchmarking of real-world follow-up data in glaucoma.

Acta ophthalmologica
2025

Fibrotic Changes in Rhegmatogenous Retinal Detachment.

International journal of molecular sciences
2025

Screening of homing and tissue-penetrating peptides by microdialysis and in vivo phage display.

Life science alliance
2025

Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market.

Acta ophthalmologica
2025

Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms.

Annals of neurology
2025

The interaction between comorbidities and sleep stages influences oxygen re-saturation characteristics.

Journal of sleep research
2025

First-line glaucoma monotherapy medication patterns in Finland during 1995-2019 based on a population-based study.

PloS one
2025

Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma.

The British journal of ophthalmology
2025

Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 Depletion.

Journal of the American Society of Nephrology : JASN
2025

Impact of signs and symptoms of dry eye disease on health-related quality of life: a cross-sectional population study among older adults.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
2025

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology &amp; clinical immunology
2025

Neovascular age-related macular degeneration on three nationwide survey and register data in Finland during 2000-2017.

Acta ophthalmologica
2025

Societal costs of decreased visual acuity: A Finnish cohort study with 15 years of registry data follow-up.

Acta ophthalmologica
2025

DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.

American journal of human genetics
2025

Melanin-Binding-Based Discovery of Topically Instilled Carbonic Anhydrase Inhibitors for Targeted Delivery and Prolonged Action in the Eye.

Molecular pharmaceutics
2025

The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study.

Eye (London, England)
2024

Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications.

Journal of clinical medicine
2025

Genome-wide association study of anterior uveitis.

The British journal of ophthalmology
2025

Association of intravitreal and topical anti-inflammatory therapies on short-term anatomical and functional outcomes following epiretinal membrane surgery.

Acta ophthalmologica
2025

Is it the right time to promote competency-based European Training Requirements in Ophthalmology? A European Board of Ophthalmology survey.

Acta ophthalmologica
2025

The Relevance and Potential Role of Orbital Fat in Inflammatory Orbital Diseases: Implications for Diagnosis and Treatment.

Ophthalmology and therapy

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença ocular tipo ilha Aland.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença ocular tipo ilha Aland

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The role of noninfectious comorbidities in the association between severe infections and risk of dementia in Finland: A nationwide registry study.
    PLoS medicine· 2026· PMID 41875076mais citado
  2. Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41860019mais citado
  3. Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
    The Lancet. Oncology· 2026· PMID 41785894mais citado
  4. Integrative Proteogenomic Analysis Identifies Genetically Supported Plasma Proteins, Metabolites, and Pathways in Glaucoma.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41649226mais citado
  5. A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion.
    The New England journal of medicine· 2026· PMID 41604638mais citado
  6. The Impact of AI on Learners' Self-Efficacy: A Meta-Analysis.
    Behav Sci (Basel)· 2026· PMID 41595098recente
  7. Seasonal Variation in Autoimmune Inner Ear Disease: A Preliminary Study.
    Otol Neurotol· 2025· PMID 41486834recente
  8. Ethical considerations for teaching with artificial intelligence: a scoping review in medical education settings.
    Int J Educ Technol High Educ· 2025· PMID 41255518recente
  9. How does emotion regulation affect adolescents' social adaptability? Building bridges for parent-child communication, empowered by AI education.
    Acta Psychol (Amst)· 2025· PMID 40845780recente
  10. Primary and secondary autoimmune disorders and hearing loss.
    Curr Opin Otolaryngol Head Neck Surg· 2025· PMID 40836789recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:178333(Orphanet)
  2. OMIM OMIM:300600(OMIM)
  3. MONDO:0010371(MONDO)
  4. GARD:10574(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q9190381(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Doença ocular tipo ilha Aland

ORPHA:178333 · MONDO:0010371
Prevalência
<1 / 1 000 000
Casos
5 casos conhecidos
Herança
X-linked recessive
CID-10
H35.5 · Distrofias hereditárias da retina
CID-11
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0268505
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades